Skip to main content

Breast Cancer Research

Ausgabe Sonderheft 1/2002

Symposium Mammographicum 2002

Inhalt (70 Artikel)

Meeting abstract

Molecular pathology of breast cancer

SR Lakhani

Meeting abstract

When do women really want to attend screening?

MG Wallis, S Wright

Meeting abstract

Mammography and women over 65

S Chandrasekharan, FA Macneill, SK Marsh, P Sauven

Meeting abstract

The accuracy of imprint cytology of breast core biopsy under ultrasound guidance

S Koshi, J Goligher, M Gottlieb, G Bradley, M Khan, R Reyes, TK Walters

Meeting abstract

Diagnosis of lymph node metastases by axillary node core biopsy in patients presenting with primary operable breast cancer

A Damera, A Evans, E Cornford, ARM Wilson, HC Burrell, JJ James, D Macmillan, SE Pinder, IO Ellis

Meeting abstract

Plastic surgery for patients with postmastectomy syndrome

NN Antonenkova, IV Zalutsky, AG Zhukovets

Meeting abstract

Sloane Project: a prospective audit of screen detected ductal carcinoma in situ

A Evans, H Bishop, K Chambers, H Dobson, IO Ellis, A Hanby, O Kearins, G Lawrence, SR Lakhani, JC Macartney, AJ Maxwell, SE Pinder, ME Wheaton, MG Wallis

Meeting abstract

Predicting breast cancer response to chemotherapy using quantitative magnetic resonance (MR) imaging

LW Turnbull, DJ Manton, M Lowry, A Maraveyas, A Chaturvedi, J Greenman, L Cawkwell, A Hubbard, A Modi, M Lind

Meeting abstract

Ductal carcinoma in situ (DCIS)

R Holland

Meeting abstract

Invasive cancer

IO Ellis

Meeting abstract

The epidemiologist's perspective

SW Duffy

Meeting abstract

Vacuum biopsy in the UK

MJ Michell

Meeting abstract

Therapeutic applications of vacuum biopsy

ARM Wilson

Meeting abstract

Multicentre evaluation of stereotactic vacuum biopsies of mammographically indeterminate or suspicious lesions

R Schulz-Wendtland, U Kettritz, I Schreer, M Murauer, K Rotter, SH Heywang-Köbrunner

Meeting abstract

Extent and stage of breast cancer

FJ Gilbert

Meeting abstract

Recording breast screening decisions: human factors and new technology

J Hatton, DS Wooding, KJ Purdy, SM Bateman, AG Gale, HC Cowley

Meeting abstract

Image features of true positive and false negative cancers in screening mammograms

S Meeson, KC Young, MG Wallis, J Cooke, A Cummin, ML Ramsdale

Meeting abstract

Roadworks ahead: a collaborative approach to process redesign

E Boal, P Durning, C Mcllveney, G Naisby, IA Cheema

Meeting abstract

Quality management in the 21st century

S Munslow, MG Wallis

Meeting abstract

Technology update

KC Young

Meeting abstract

Assistant practitioners: a success story

R Lander, S Milton

Meeting abstract

Complications of breast core biopsy

A O'Connor, EJ Wylie, LJ Nuttall

Meeting abstract

Decubitus position for horizontal approach mammotome: is it possible?

E Lightfoot, A Pavis, A Murphy, J Berry-Smith

Meeting abstract

Evaluation of the need for magnification views in the assessment of calcification in computerised mammography

G Wivell, R Hiscock, M Trotter, M Shaw, J Pilling, ERE Denton

Meeting abstract

Welcome to North Wales breast screening

W Thomas

Meeting abstract

To mag or not mag: that was the question?

S Laybourne, J Austin, G Brown, J MacDonald

Meeting abstract

Computer aided detection

P Taylor

Meeting abstract

Are there demographic differences in film reading skill?

AG Gale, HC Cowley, SM Bateman, DS Wooding

Meeting abstract

Is it safe to allow general practitioners open access to breast imaging?

GR Clough, A Hill, JC Liston

Meeting abstract

A 10-year review of lymphoma detected by breast screening

A O'Connor, EJ Wylie

Meeting abstract

Diagnosis of dermal calcification

D McBurnie

Meeting abstract

Review of clinical trials

RE Hendrick

Meeting abstract

Phylloides tumours: review of 42 cases

S Chandrasekharan, FA Macneill, SK Marsh, P Sauven, R Whitney

Meeting abstract

Reconstruction

RM Rainsbury

Meeting abstract

Imaging implants

AJ Potterton

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.